865202-97-7 Usage
Uses
Used in Pharmaceutical Industry:
(S)-2-(4-(((1H-benzo[d]iMidazol-2-yl)Methyl)(5,6,7,8-tetrahydroquinolin-8-yl)aMino)butyl)isoindoline-1,3-dione is used as a potential therapeutic agent for various medical conditions due to the presence of pharmacologically active moieties such as benzimidazole and isoindoline-1,3-dione. These groups are known to exhibit biological activities, which may contribute to the compound's effectiveness in treating specific diseases or disorders.
Used in Drug Development:
In the field of drug development, (S)-2-(4-(((1H-benzo[d]iMidazol-2-yl)Methyl)(5,6,7,8-tetrahydroquinolin-8-yl)aMino)butyl)isoindoline-1,3-dione can be utilized as a lead compound for the design and synthesis of new drugs. Its unique structure and functional groups may serve as a foundation for the development of novel therapeutic agents with improved efficacy and selectivity.
Used in Chemical Research:
(S)-2-(4-(((1H-benzo[d]iMidazol-2-yl)Methyl)(5,6,7,8-tetrahydroquinolin-8-yl)aMino)butyl)isoindoline-1,3-dione can also be employed in chemical research as a model compound for studying the properties and reactivity of complex organic molecules. This may lead to a better understanding of the structure-activity relationships and the development of new synthetic strategies for the preparation of similar compounds with potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 865202-97-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,5,2,0 and 2 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 865202-97:
(8*8)+(7*6)+(6*5)+(5*2)+(4*0)+(3*2)+(2*9)+(1*7)=177
177 % 10 = 7
So 865202-97-7 is a valid CAS Registry Number.
865202-97-7Relevant academic research and scientific papers
Compositions of CXCR4 inhibitors and methods of preparation and use
-
Page/Page column 76; 82, (2020/02/20)
The present invention provides compositions and methods of use for treating, preventing, or ameliorating a disease, disorder, or condition associated with a chemokine receptor such as CXCR4.
Process for the synthesis of CXCR4 antagonist
-
Page/Page column 15-16, (2010/02/14)
This invention relates to a process for synthesizing heterocyclic pharmaceutical compound which binds to the CXCR4 chemokine receptor. In one embodiment, the process comprises: a) reacting a 5,6,7,8-tetrahydroquinolinylamine and an alkyl aldehyde bearing a phthalimide or a di-tertiary-butoxycarbonyl (di-BOC) protecting group to form an imine; b) reducing the imine to form a secondary amine; c) reacting the secondary amine with a haloalkyl substituted heterocyclic compound, to form a phthalimido-protected or di-tert-butoxycarbonyl protected tertiary amine; and d) hydrolyzing the protected amine to obtain a compound having Formula I′
